Efficacy of carfilzomib in the treatment of relapsed and (or) refractory multiple myeloma: a meta-analysis of data from clinical trials.
about
Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma.Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.
P2860
Efficacy of carfilzomib in the treatment of relapsed and (or) refractory multiple myeloma: a meta-analysis of data from clinical trials.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Efficacy of carfilzomib in the ...... of data from clinical trials.
@ast
Efficacy of carfilzomib in the ...... of data from clinical trials.
@en
type
label
Efficacy of carfilzomib in the ...... of data from clinical trials.
@ast
Efficacy of carfilzomib in the ...... of data from clinical trials.
@en
prefLabel
Efficacy of carfilzomib in the ...... of data from clinical trials.
@ast
Efficacy of carfilzomib in the ...... of data from clinical trials.
@en
P2093
P1433
P1476
Efficacy of carfilzomib in the ...... of data from clinical trials.
@en
P2093
Baoan Chen
Runzhe Chen
Xiaoping Zhang
P304
P577
2016-10-01T00:00:00Z